EQUITY-METHOD INVESTMENTS (Tables)

6 Months Ended

Jun. 30, 2020

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Condensed Financial Information of Equity Method Investments

The following presents condensed financial information as of June 30, 2020 and December 31, 2019 and for the three and six months ended June 30, 2020 and 2019 (in thousands).

Consolidated statements of comprehensive income (loss) data:
	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Net revenue	$	6,520	$	4,789	$	12,011	$	9,396
Cost of revenue	4,772		3,432		8,712		6,799
Gross profit	1,748		1,357		3,299		2,597
Net income	633		257		1,150		507
Equity in net income	316		129		574		254
Consolidated balance sheet data:
					As of
					June 30, 2020		December 31, 2019
Current assets					$	8,401	$	7,643
Noncurrent assets					3,387		3,846
Current liabilities					1,213		903
Noncurrent liabilities					498		659

The following presents condensed financial information as of June 30, 2020 and December 31, 2019 and for the three and six months ended June 30, 2020 and 2019 (in thousands).

Consolidated statements of comprehensive income (loss) data:
	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Net revenue	$	11,972	$	9,925	$	22,480	$	19,163
Cost of revenue	9,341		7,468		17,981		14,517
Gross profit	2,631		2,457		4,499		4,646
Net income	1,391		1,028		1,999		1,876
Equity in net income	696		514		1,000		938
Consolidated balance sheet data:
					As of
					June 30, 2020		December 31, 2019
Current assets					$	14,684	$	11,111
Noncurrent assets					1,699		2,033
Current liabilities					2,680		1,228
Noncurrent liabilities					745		956